{"code":"C67450","name":"Tissue Culture Infectious Dose 50%","terminology":"ncit","version":"26.09d","conceptStatus":"DEFAULT","leaf":false,"active":true,"synonyms":[{"name":"[TCID_50]","termType":"PT","type":"FULL_SYN","typeCode":"P90","source":"FDA","subSource":"SPL"},{"name":"TISSUE CULTURE INFECTIOUS DOSE 50%","termType":"PT","type":"FULL_SYN","typeCode":"P90","source":"FDA","code":"TCID 50","subSource":"Potency (C-DRG-00501)"},{"name":"TISSUE CULTURE INFECTIOUS DOSE 50%","termType":"SY","type":"FULL_SYN","typeCode":"P90","source":"FDA","subSource":"SPL"},{"name":"[TCID_50]","termType":"AB","type":"FULL_SYN","typeCode":"P90","source":"HL7"},{"name":"TISSUE CULTURE INFECTIOUS DOSE 50%","termType":"PT","type":"FULL_SYN","typeCode":"P90","source":"HL7"},{"name":"50 Percent Tissue Culture Infective Dose","termType":"SY","type":"FULL_SYN","typeCode":"P90","source":"NCI"},{"name":"50% Tissue Culture Infective Dose","termType":"SY","type":"FULL_SYN","typeCode":"P90","source":"NCI"},{"name":"TCID50","termType":"AB","type":"FULL_SYN","typeCode":"P90","source":"NCI"},{"name":"TCID_50","termType":"AB","type":"FULL_SYN","typeCode":"P90","source":"NCI"},{"name":"Tissue Culture Infectious Dose 50%","termType":"PT","type":"FULL_SYN","typeCode":"P90","source":"NCI"},{"name":"{TCID50}","termType":"SY","type":"FULL_SYN","typeCode":"P90","source":"NCI"},{"name":"Tissue Culture Infectious Dose 50%","type":"Preferred_Name","typeCode":"P108"},{"name":"50% tissue culture infectious dose","termType":"PT","type":"FULL_SYN","typeCode":"P90","source":"UCUM"},{"name":"[TCID_50]","termType":"SY","type":"FULL_SYN","typeCode":"P90","source":"UCUM"},{"name":"{TCID50}","termType":"AB","type":"FULL_SYN","typeCode":"P90","source":"UCUM"}],"definitions":[{"definition":"A potency unit defined as a minimal dose of infectious material at which preparation causes cytopathic effects (changes in the morphology and metabolism of tissue culture cells, indicating cell death, due to suspected infection) in the 50% of the tissue culture-containing flasks inoculated with that dilution of infectious material in the product potency assay or pathogen activity assay.","code":"P97","type":"DEFINITION","source":"NCI"}],"properties":[{"code":"P322","type":"Contributing_Source","value":"FDA"},{"code":"P322","type":"Contributing_Source","value":"HL7"},{"code":"P322","type":"Contributing_Source","value":"UCUM"},{"code":"P317","type":"FDA_Table","value":"Potency (C-DRG-00501)"},{"code":"P366","type":"Legacy Concept Name","value":"Tissue_Culture_Infection_Dose_50"},{"code":"P106","type":"Semantic_Type","value":"Quantitative Concept"},{"code":"P207","type":"UMLS_CUI","value":"C1883346"}]}